InvestorsHub Logo
Followers 13
Posts 1547
Boards Moderated 0
Alias Born 06/14/2018

Re: microcapbiotech post# 26595

Sunday, 06/16/2019 3:42:45 PM

Sunday, June 16, 2019 3:42:45 PM

Post# of 34626
I've just been thinking …
I said in post # 26595, "MRKR's technology is worth MORE than Juno's".
Is that true?, how do you judge that?, what are the positives and negatives of CAR-T versus MultiTAA?

CAR-T, sometimes it's works great, sometimes a little, sometimes kills patients. Negative side effects, worst is CRS. It's genetically engineered (which is part of the side effects problem). Options to improve CAR-T??

MultiTAA, Multi Antigen Targeted T Cell. Not genetically manipulated (great), very positive results so far, NO CRS, doesn't kill patients.

Options to improve MultiTAA - exponential.
Many different cancers/tumors out there.
Ability to add many different antigens targets based of that particular cancer/tumor.
Ability to add other therapies like adding checkpoint inhibitors.
Ability to combine with other therapies like Actinium's AWE.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent MRKR News